Yingkun Xu

24PUBLICATIONS
19CO-AUTHORS
Te urupare me te whai wāhi Māori ki te mātauranga (Māori responsiveness and engaged education)Oncology and carcinogenesis not elsewhere classifiedPredictive and prognostic markersBioinformatic methods developmentCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jan 15, 2026
Letter to the Editor: MRI-based habitat analysis for pathologic response prediction after neoadjuvant chemoradiotherapy in rectal cancer-a multicenter study.

Peizhi Zhang, Yanjie Wang, Yingkun Xu

|Aug 29, 2023
WITHDRAWN: Comprehensive Analysis of the Role of CXCL Family Members in Clear Cell Renal Cell Carcinoma

Jiechuan Qiu, Zicheng Wang, Peizhi Zhang

|Sep 19, 2022
Cuprotosis-Related Genes: Predicting Prognosis and Immunotherapy Sensitivity in Pancreatic Cancer Patients.

Yingkun Xu, Han Li, Ailin Lan

|Sep 09, 2022
Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer.

Yingkun Xu, Meiying Shen, Yang Peng

|Sep 05, 2022
Prognostic Signature and Therapeutic Value Based on Membrane Lipid Biosynthesis-Related Genes in Breast Cancer.

Yingkun Xu, Yudi Jin, Shun Gao

|Aug 19, 2022
Comprehensive Multiomics Analysis Reveals Potential Diagnostic and Prognostic Biomarkers in Adrenal Cortical Carcinoma.

Xiunan Li, Jiayi Li, Leizuo Zhao

Pageof 4

Frequent Collaborators

14 joint publications

Guangzhen Wu

7 joint publications

Qifei Wang

5 joint publications

Xiangyu Che

5 joint publications

Shengchun Liu